Accredited InvestorsEmployee ShareholdersInstitutionsPrivate Companies Who We Serve Trading and Investing Data Solutions Private Asset Custody Institutional TradingForge ProTrade private companies with Forge’s institutional brokerage tool​Browse CompaniesIndividual InvestingForge MarketsFind new private company investment opportunities​Forge DataAnalyze private markets via Forge’s intuitive web application​Forge Private Market Index​Monitor a benchmark for actively traded private companies ​Forge Accuidity Private Market Index​Invest in an institutionally-managed diversified basket of private companies (QPs only)​Self-Directed IRAForge TrustInvest in private companies and other alternative assets through a tax-advantaged Self-Directed IRASolutions All Insights Private Market Reports Market Insights Buying and Selling Pre-IPO​ All Reports​Private Market UpdatesForge Investment OutlookStartup News and Trends​Private Market Data and Analytics​Tech IPO Calendar for 2024​Private Market Explained​Buying Pre-IPO Shares​Selling Pre-IPO SharesGlossaryVideosFAQsInsights About UsLeadershipInvestor RelationsPeople & CultureCareers About
Log InSign Up
Who We Serve
Solutions
Insights
About
Who We Serve
Solutions
Trading and Investing
Institutional Trading
Individual Investing
Data Solutions
Private Asset Custody
Self-Directed IRA
Insights
Private Market Reports
Market Insights
Buying and Selling Pre-IPO​
About
Log In
Sign Up
Secondary Marketplace / Trade Private Companies / Buy and Sell DexCare Stock

DexCare Stock

www.dexcare.com/Enterprise Software / Business OperationsFounded: 2016

DexCare, founded in 2020, is a digital health company aiming to optimize health system capacity through data-driven solutions. The company's mission is to create seamless, personalized healthcare experiences by intelligently allocating health system resources. DexCare's platform seeks to integrate with healthcare providers' existing systems to manage patient demand, service line growth, and care delivery. The company is based in Seattle, Washington.

Buy or sell DexCare stockLearn more about DexCare IPO

Register To Buy and Sell Shares

For more details on private stock price information, financing and valuation for DexCare, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value

Powered by Forge Data

Access DexCare’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like DexCare.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Access Stock Price

Animation displayed is not current and securities are shown for illustrative purposes only.

DexCare investors also invested in these private companies

ICONIQ Growth
Transformation Capital
Kaiser Permanente Ventures
Frist Cressey Ventures
SpringRock Ventures
Providence Ventures
Define Ventures
Mass General Brigham Ventures

Team

Management Team

Derek Streat
Co-Founder & Chief Executive Officer
Rick Pittenger
Chief Technology Officer
Julia Millard
Chief Customer Experience Officer
Jamie Gier
Chief Marketing Officer
Robin Borg
Chief People Officer
Catherine Stach
Chief Product Officer
Sean O'Connor
Co-Founder & Chief Commercial Officer

Board Members

David Kereiakes
Providence Ventures
Lynne O'Keefe
Define Ventures
Todd Cozzens Ph.D
Transformation Capital

DexCare stock FAQs

plusminus

Can you buy DexCare stock?

As DexCare is not publicly traded, purchasing its stock is not available to everyone. To buy the stock of a private company like DexCare, you must be an accredited investor. If you meet the accreditation criteria, you can register for Forge’s Secondary Marketplace to buy private market stock. If you are not an accredited investor, discover how to begin the process to potentially qualify for new investment opportunities.
plusminus

How to buy DexCare stock?

To invest in a private company like DexCare through Forge, you must first qualify as an accredited investor. (Learn more about the accreditation process.)
  1. Create a free account to access Forge’s marketplace.
  2. Express your interest in specific investments. Within Forge Markets, you will find detailed pricing and financing information for thousands of private companies.
  3. Throughout this process, a dedicated Forge Private Market Specialist will be available to address any questions you may have and to guide you seamlessly through each step of the transaction.
plusminus

Can you sell DexCare stock?

Yes, you may be able to sell your DexCare stock, subject to certain conditions. Forge can help you facilitate the sale of your stock in a manner that aligns with your needs and the company's interests. If you are looking for liquidity, register with us today to begin the process. A dedicated Forge Private Market Specialist will be available to address any questions you may have along the way.
plusminus

How to sell DexCare stock?

If you hold private company shares of - whether as an employee or an early investor - Forge can help you sell them.
  1. Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have.
  2. Indicate your interest to sell your DexCare stock on our platform.
  3. Work with your dedicated Private Market Specialist who'll help guide you through every step of the transaction.
plusminus

Is DexCare a public company?

No, DexCare is a privately held company and is currently not publicly traded on any stock markets including NYSE or NASDAQ.
plusminus

What is DexCare’s stock price?

DexCare is a privately held company and therefore does not have a public stock price. However, you may access DexCare’s private market stock price with Forge Data.
plusminus

What is DexCare’s stock ticker symbol?

DexCare does not have an official ticker symbol because this company is not currently publicly traded.
plusminus

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

Other companies like DexCare in the Business Operations sector

Climeworks
Sector
Enterprise Software / Business Operations
 
 
Electric AI
Sector
Enterprise Software / Business Operations
Last Round Est. Valuation
$1.04B
Navan
Sector
Enterprise Software / Business Operations
Last Round Est. Valuation
$9.2B
C2FO
Sector
Enterprise Software / Business Operations
Last Round Est. Valuation
$2.14B
Pax8
Sector
Enterprise Software / Business Operations
Last Round Est. Valuation
$1.7B
Nile
Sector
Enterprise Software / Business Operations
Last Round Est. Valuation
$725.72MM
Ironclad
Sector
Enterprise Software / Business Operations
Last Round Est. Valuation
$3.29B
Guideline
Sector
Enterprise Software / Business Operations
Last Round Est. Valuation
$1.15B
ShipBob
Sector
Enterprise Software / Business Operations
Last Round Est. Valuation
$2.01B
BUSINESS WIRE 06/27/2023

DexCare Appoints Robin Borg as Chief People Officer to Cultivate World-Class Talent to Fuel Growth

DexCare, Inc., the leading patient demand and care access platform, has named Robin Borg, SPHR, as chief people officer (CPO). As CPO, Borg strengthens DexCare’s recruiting and talent development process, and will further unify teams across locations. With more than 30 years of experience in human resources, Borg plays an essential role to ensure DexCare attracts and retains top-notch talent to support the company’s continued growth.
BLOOMBERG 06/21/2023

DexCare Closes $75M in Series C Funding, Led by ICONIQ Growth, to Accelerate Market Expansion of its Care Access Platform

DexCare, Inc., the leading patient demand and care access platform, today announced the close of its $75 million Series C funding round led by ICONIQ Growth. The funding will advance DexCare’s platform, which extends limited health-system capacity to serve patients faster and to precisely manage the supply and demand of digital-care access.
BUSINESS WIRE 05/01/2023

DexCare Reports Banner Year: Expands Access to Care to Millions of Patients and Maintains Rapid Company Growth

DexCare, Inc., the leading patient demand and care access platform, today announced its industry impact and business growth results, commemorating its two-year anniversary following its spinout from Providence.
Browse More Insights
Trending Companies

Frequently Asked Questions

Updated on: Jul 26, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.